0% found this document useful (0 votes)
28 views8 pages

Anti Retroviral Drugs by Abdul Rehman

Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
28 views8 pages

Anti Retroviral Drugs by Abdul Rehman

Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 8

Anti Retroviral Drugs or Anti-

HIV
By Abdul Rehman
3rd prof
Cadson College of Pharmacy

◾ Classification:
◾NRTIs:
Nucleotide\Nucleoside reverse transcriptase
inhibitors include drugs like zidovudine,
lamivudine & abacavir.

Mechanism of Action:
▪️RT is a RNA dependent DNA polymerase which
converts RNA into DNA double helix
▪️NRTIs are 1st phosphorylated into active form
and then are incorporated into DNA chain by RT.
▪️ Because 3 hydroxyl group is not present in
NRTIs, DNA chain can’t further grow and is
terminated

Pharmacokinetics:
▪️ Administered orally (zidovudine can also be
administered IV)
▪️ Excretion occurs through urine except
abacavir.
Therapeutic uses:
HIB treatment

Adverse effect:
▪️ Toxicities like prepheral neuropathy,
pancreatitis & lipoatropy.
▪️ Abacavir can cause hypersensitivity reaction.

Resistance:
Occurs due to mutation at viral RT codon 184.

◾NNRTIs:
Includes delaviridine & nevirapine

Mechanism of Action:
▪️ Don’t require activation
▪️Bind at allosteric site of RT and inhibit it.
Pharmacokinetics:
▪️ Oral Administration (tablet)

Therapeutic uses:
HIV treatment

Adverse effect:
▪️Skin rash
▪️ Hepatotoxicity
▪️ Psychiatric effects

◾ Entry Inhibitors:
includes Enfuvirtide &Maraviroc which is a
polypeptide

Mechanism of Action:
▪️It is a fusion inhibitor which stops virus entry
into host cell.
▪️Viral transmembrane glycoprotein Gp41 is
responsible for virus’s entry due to some
conformational changes occuring in it after
fusion.
▪️ Enfuvirtide binds to Gp41 and prevent these
conformational changes.
▪️ Maraviroc blocks CCR5 co-receptor which
facilities gp41

Pharmacokinetics:
Is a peptide so injected Subcutaneously

Therapeutic uses:
Used in HIV patients which are already on
multiple HIV medications
Adverse effect:
▪️ Injection site irritation
▪️prepheral neuropathy(numbness, weakness)
◾Integrase Inhibitors:
Includes Bictegravir & Raltegravir

Mechanism of Action:
▪️Integrase is responsible for insertion of viral
DNA into host chromosomal DNA.
▪️These drugs bind to this enzyme and prevent
the above process of integration.

Pharmacokinetics:
▪️Well orally absorbed
▪️ Metabolism occurs through glucoronidation
▪️ Excretion occurs through bile

Therapeutic uses:
HIV infection
Adverse effect:
Well tolerable so general ADRs like headache,
nausea, Diarrhea etc

Resistance:
▪️Can occur due to single point mutation in
Integrase gene.
▪️Cross resistance can also occur.

◾ Protease Inhibitors:
Includes Darunavir, Atazanavir & Indinavir

Mechanism of Action:
▪️ Viral Protease or retropepsin is responsible for
cleavage of viral polyprotien into a no. of essential
enzymes.
▪️These drugs reversibly inhibit this enzyme.
Pharmacokinetics:
▪️Fatty meals increase bioavailability.
▪️ metabolized by CYP3A4.
▪️ Metabolism is extensive and very little drug is
excreted through urine.

Therapeutic uses:
▪️HCV infection
▪️HIV infection

Adverse effect:
▪️ General
▪️ chronic administration results in fat
redistribution
▪️ Disturbances in glucose and lipid metabolism.

Resistance:
Can occur due to mutations in protease gene

You might also like